The Strategic Outsourcing: How Contract Manufacturing for Biologics Is Driving Drug Development
The development and manufacturing of biologic drugs is a complex and capital-intensive endeavor. Contract manufacturing for biologics , particularly for fill-finish services, has emerged as a strategic solution for pharmaceutical companies of all sizes. The global biologics fill-finish services market, valued at USD 9.3 billion in 2025 and projected to grow to USD 15.0 billion by...
0 Комментарии 0 Поделились 254 Просмотры 0 предпросмотр